Predictive factors for the benefit of perioperative FOLFOX for resectable liver metastasis in colorectal cancer patients (EORTC Intergroup Trial 40983). (Q53388486)
Jump to navigation
Jump to search
scientific article published in March 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Predictive factors for the benefit of perioperative FOLFOX for resectable liver metastasis in colorectal cancer patients (EORTC Intergroup Trial 40983). |
scientific article published in March 2012 |
Statements
Predictive factors for the benefit of perioperative FOLFOX for resectable liver metastasis in colorectal cancer patients (EORTC Intergroup Trial 40983) (English)
Werner Scheithauer
Fédération Francophone de Cancérologie Digestive (FFCD)
EORTC Gastro-Intestinal Tract Cancer Group
Australasian Gastro-Intestinal Trials Group (AGITG)
Meg Finch-Jones
Halfdan Sorbye
Murielle Mauer
Graeme J Poston
Peter M Schlag
Philippe Rougier
Daniel Jaeck
Darius Mirza
Rowan W Parks
Laurence Collette
Eric Van Cutsem
Cancer Research UK (CRUK)
Arbeitsgruppe Lebermetastasen und-tumoren in der Chirurgischen Arbeitsgemeinschaft Onkologie (ALM-CAO)
Bengt Glimelius